New Jersey 2020-2021 Regular Session Status: Introduced

S2934 —

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed General Assembly
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2020-2021 Regular Session. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Identical bill: A4721 —

Bill Text

What changed in the latest version

105 added · 28 removed

Plain-language change summary

The amendment adds a fiscal estimate section that outlines the expected annual revenue gains from a 2.5 percent corporation business tax (CBT) surtax, estimated to generate between $243 million and $333 million for the General Fund in fiscal years 2021, 2022, and 2023. It removes a provision that would suspend the surtax if the federal corporate income tax rate increased. This change clarifies the financial implications of the surtax while eliminating the conditional aspect regarding federal tax rates.

→
Previous
Latest
S2934 SBA Statement 9/22/20 SENATE BUDGET AND APPROPRIATIONS COMMITTEE   STATEMENT TO   SENATE, No.
S2934 FISCAL ESTIMATE   LEGISLATIVE FISCAL ESTIMATE SENATE, No.
  STATE OF NEW JERSEY   DATED:
2934 STATE OF NEW JERSEY 219th LEGISLATURE   DATED:
 SEPTEMBER 22, 2020         The Senate Budget and Appropriations Committee reports favorably Senate Bill No.
SEPTEMBER 29,     SUMMARY   Synopsis:
2934.
Imposes CBT surtax at rate of 2.5 percent until December 31, 2023.
      This bill imposes the existing corporation business tax (CBT) surtax at a rate of 2.5 percent until December 31, 2023.  However, if the federal corporate income tax rate is increased to its pre-Tax Cut and Jobs Act (35% of taxable income) level, the surtax will be suspended at the end of a taxpayer’s current privilege period.  Under current law, the CBT surtax rate was reduced to 1.5 percent on January 1, 2020, and is scheduled to be eliminated after December 31, 2021.        The bill also requires the Director of the Division of Taxation in the Department of the Treasury to waive all penalties that a taxpayer may incur because of the retroactive imposition of the surtax rate.
Type of Impact:
Annual State revenue gain to General Fund.
Agencies Affected:
Department of the Treasury.
    Office of Legislative Services Estimate Fiscal Impact        FY 2021      FY 2022         FY 2023   State Revenue Gain $243 million to $333 million $245 million to $342 million $446 million to $664 million         ·         The Office of Legislative Services (OLS) projects additional revenues of $243 million to $333 million in FY 2021 from increasing the corporation business tax (CBT) surtax rate from 1.5 percent to 2.5 percent.  Since the surtax is currently set to expire on December 31, 2021, the impact of this bill will be greater in FY 2022 through FY 2024.  The OLS projects revenues to increase by $245 million to $342 million in FY 2022 and $446 million to $664 million in FY 2023.  If the bill is enacted, the surtax would be set to expire after December 31, 2023;
thus, the surtax would fully impact FY 2021 through parts of FY 2024.  Revenue from the surtax would start to decline during the latter half of FY 2024 and onward.
    BILL DESCRIPTION         This bill imposes the existing CBT surtax at a rate of 2.5 percent until December 31, 2023.  However, if the federal corporate income tax rate is increased to its pre-Tax Cut and Jobs Act (35 percent of taxable income) level, the surtax will be suspended at the end of a taxpayer’s current privilege period.  Under current law, the CBT surtax rate was reduced to 1.5 percent on January 1, 2020, and is scheduled to be eliminated after December 31, 2021.        The bill also requires the Director of the Division of Taxation in the Department of the Treasury to waive all penalties that a taxpayer may incur because of the retroactive imposition of the surtax rate.
  FISCAL IMPACT:
    FISCAL ANALYSIS   EXECUTIVE BRANCH         As part of the Governor’s revised FY 2021 budget proposal, the Executive projected an increase in the CBT surtax rate from 1.5 percent to 2.5 percent would yield $210 million in additional revenue for FY 2021.
      The Office of Legislative Services (OLS) is projecting additional revenues of $244.4 million from the increased surtax rate.  As part of the Governor’s revised FY 2021 budget proposal, the Executive projected an increase in the CBT surtax rate from 1.5% to 2.5% to yield $210 million in additional revenue for FY 2021.  Given the complexity of the CBT and the difficultly of forecasting both corporate financial performance and taxpayer decisions, which can affect tax liability in the short run, the OLS and the Executive’s estimates should each be considered as within the range of the bill’s likely impact.
    OFFICE OF LEGISLATIVE SERVICES         The OLS projects additional revenues of $243 million to $333 million in FY 2021 from increasing the CBT surtax rate from 1.5 percent to 2.5 percent.  Since the surtax is currently set to expire on December 31, 2021, the impact of this bill will be greater in FY 2022 through FY 2024.  The OLS projects revenues to increase by $245 million to $342 million in FY 2022 and $446 million to $664 million in FY 2023.  If the bill is enacted, the surtax would be set to expire after December 31, 2023;
thus, the surtax would fully impact FY 2021 through parts of FY 2024.  Revenue from the surtax would start to decline during the latter half of FY 2024 and onward.
      The OLS does not have access to taxpayer data, so it cannot determine the amounts collected from the current surtax.  The OLS only has access to audited collections from the State’s Comprehensive Annual Financial Report for FY 2018, the last fiscal year unaffected by the surtax and other significant alterations to the CBT tax base (i.e.
federal and State policy changes).  The FY 2018 collections are used as the tax base for this analysis, since that fiscal year was the last unaffected by any major policy changes at both the State and federal levels.  Some of those policy changes did broaden the tax base, such as combined reporting, and thus, the surtax likely yielded more revenue than originally estimated as a result.  So, the OLS also utilized audited collections from FY 2019, which reflects the implementation of the tax base changes and favorable economic conditions.
      If the OLS uses FY 2018 audited collections and certain adjustments to determine a tax base, the 2.5 percent surtax would yield roughly $584 million annually.  Under identical conditions, a 1.5 percent surtax would yield roughly $328 million annually.   Similarly, using FY 2019 audited collections to determine the CBT tax base, the 2.5 percent surtax would yield roughly $876 million and the 1.5 percent surtax would yield $526 million.  The bill’s impact is the difference between the set of 2.5 percent estimates and 1.5 percent estimates, so the bill’s range of likely outcomes is anywhere between $256 million ($584 million less $328 million) and $350 million ($876 million less $526 million).  To account for current economic conditions impacting corporate financial performance and the retroactive imposition of the 2.5 percent surtax rate, the OLS adjusted its estimate to $243 million to $333 million for FY 2021.
      Since the surtax is currently set to expire on December 31, 2021, the impact of this bill will be greater in FY 2022 through FY 2024.  The OLS projects revenues to increase by $245 million to $342 million in FY 2022 and $446 million to $664 million in FY 2023.
Section:
Revenue, Finance and Appropriations Analyst:
Jordan M.
DiGiovanni Revenue Analyst Approved:
Frank W.
Haines III Legislative Budget and Finance Officer     This legislative fiscal estimate has been produced by the Office of Legislative Services due to the failure of the Executive Branch to respond to our request for a fiscal note.
  This fiscal estimate has been prepared pursuant to P.L.1980, c.67 (C.52:13B-6 et seq.).
View plain text versions (3)

Sponsorship breakdown

Export CSV (upgrade) →

0 sponsors · 0 co-sponsors · 120 not signed on

Sponsors (0)

None.

Co-sponsors (0)

None.

Not signed on (120)

120 members have not signed on to this bill.

Show all 120 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What is the current status of S2934?
This bill died with 2020-2021 Regular Session. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track S2934?
Track S2934 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S2934

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of S2934

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →